Northwestern Mutual Wealth Management’s Maravai LifeSciences MRVI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.08K	Buy	+2,500	New	+$8.48K	﹤0.01%	3190
2025 Q4	–	Sell	-1,842	Closed	-$5.29K	–	4169
2025 Q3	$5.29K	Buy	+1,842	New	+$4.7K	﹤0.01%	3129
2024 Q4	–	Sell	-888	Closed	-$7.38K	–	3791
2024 Q3	$7.38K	Buy	+888	New	+$7.68K	﹤0.01%	2794
2024 Q2	–	Sell	-43	Closed	-$373	–	3700
2024 Q1	$373	Sell	43 -7	-14%	-$47	﹤0.01%	3338
2023 Q4	$328	Buy	+50	New	+$323	﹤0.01%	3316
2023 Q2	–	Sell	-37	Closed	-$518	–	3509
2023 Q1	$518	Buy	37 +21	+131%	+$302	﹤0.01%	3103
2022 Q4	$229	Buy	+16	New	+$252	﹤0.01%	3175
2021 Q2	–	Sell	-218	Closed	-$8K	–	3108
2021 Q1	$8K	Buy	+218	New	+$7.22K	﹤0.01%	2351

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's MRVI Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 2,500 shares worth $7.08K. The stake represents ﹤0.01% of the portfolio and ranks #3190 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in MRVI as recently as Q3 2025.

Northwestern Mutual Wealth Management first reported a position in MRVI in Q1 2021 and has held it in 8 quarters since. The position peaked at $8K in Q1 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Northwestern Mutual Wealth Management held 2,500 shares of Maravai LifeSciences worth $7.08K as of Q1 2026.
Maravai LifeSciences was a new Northwestern Mutual Wealth Management position in Q1 2026.
Maravai LifeSciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3190 holding.
Northwestern Mutual Wealth Management first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 8 quarters since.
Northwestern Mutual Wealth Management's Maravai LifeSciences position peaked at $8K in Q1 2021.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.